Inistrated volume (p value = 0.313) and the variety of the contrast medium (p worth = 0.273) have been equivalent between the 2 groups in our study. There was just a single essential difference involving the case and control groups (age on the sufferers), which could potentially distort the assessment in the efficacy of L-carnitine. Therefore, we adjusted the result in the study statistically determined by the confounding components. A greater baseline plasma amount of NGAL was significantly connected to having a family members history of cardiac ailments (p value 0.001), lower BMI (p worth = 0.008), and greater troponin T level (p value = 0.011); these differences, even so, failed to constitute statistical significance.Figure 1. Enrollment of your individuals scheduled for elective percutaneous coronary intervention.The Journal of Tehran University Heart CenterJ Teh Univ Heart Ctr 12 (2) April, 2017 ://jthc.tums.ac.irThe Journal of Tehran University Heart CenterTable 1. Patients’ demographic and clinical qualities based on the study groups Things Quantity of Individuals Age (y) Female Sex BMI (kg/m )Mohammad Mohammadi et al.Total 202 60.00.five 64 (31.7) 27.0.3 72 (35.6) 76 (37.6) 103 (50.9) 122 (60.4) 52 (25.7) 17 (eight.four) 50 (15-70) 137 (67.eight) 140 (69.three) 69 (34.2) 76 (37.six) 85 (42.1) 178 (88.1) 61(30.2) 145 (71.eight) 88 (43.five) 0.86 (0.46-1.60) 11.86 (3-3057) 1.70 (0.48-11.18) 80 (39.6) 77 (38.1) 45 (22.two) 180 (89.1) 22 (ten.9) 170 (84.two) 32 (15.8) 28 (12-82)Carnitine Group 91 (45.1) 62.0.0 31 (34.1) 27.1.two 30 (33.7) 30 (33.7) 40 (43.9) 51 (56.1) 20 (22.0) six (six.six) 50 (15-65) 61 (67.0) 58 (63.7) 28 (30.eight) 39 (42.eight) 42 (46.2) 82 (90.1) 25 (27.five) 71 (78.0) 39 (42.8) 0.85 (0.56-1.40) 12.39 (3-3057) 1.60 (0.86-9.99) 37 (40.6) 37 (40.6) 17 (18.7) 79 (86.eight) 12 (13.two) 79 (86.8) 12 (13.2) 28 (12-68) 72 (79.1) four (four.four) ten (10.9) 5 (5.5) 200 (100-500)Control Group 111 (54.9) 57.01.two 33 (29.7) 26.9.3 42 (37.8) 46 (41.four) 59 (53.1) 71 (63.9) 32 (28.eight) 11 (9.9) 50 (35-70) 76 (68.five) 82 (73.9) 41 (36.9) 37 (33.3) 43 (38.7) 96 (86.5) 36 (32.4) 75 (67.six) 49 (44.1) 0.86 (0.46-1.60) 11.18 (3-2013) 1.75 (0.48-11.18) 43 (38.7) 40 (36.0) 28 (25.two)P value 0.001 0.510 0.746 0.472 0.216 0.497 0.252 0.268 0.398 0.442 0.828 0.120 0.358 0.164 0.288 0.428 0.455 0.099 0.203 0.399 0.210 0.255 0.Family members History for CAD Existing Smoker Dyslipoproteinemia Hypertension Diabetes Mellitus Opium Ejection fraction Medication History Statin Beta-blocker ACEI ARB Clopidogrel Aspirin Antidiuretic agent Anti-ischemic Diuretics Serum creatinine Troponin T CK-MB Angiography Result SVD 2VD 3VD Style of stents DES BMS Stent No.KGF/FGF-7 Protein manufacturer 1 two Stent Length (mm) Contrast form Iodixanol (320) ; Osmolality (290) 0.CDCP1 Protein custom synthesis 343 101 (91.PMID:23991096 9) 10 (9.0) 0.342 91 (81.9) 20 (18.0) 30 (12-82) 75 (67.six) 11 (9.9) 17 (15.three) eight (7.two) 200 (100-500) 0.313 0.108 0.273 147 (72.8) 15 (7.4) 27 (13.4) 13 (6.four) 200 (100-500)Iopromide (300) ; Osmolality (607) Iopromide (370) ; Osmolality (774) Iohexol (350) ; Osmolality (844) Contrast volume (mL) Information are presented as suggests D, medians (interquartile variety), or n Generic name of your contrast medium agent (mgI/mL) Osmolality (mosm/kg of water) BMI, Physique mass index; CAD, Coronary artery illness; ACEI, Angiotensin-converting enzyme inhibitor; ARB, Angiotensin-receptor blocker; CK-MB, Creatine kinase B; SVD, Single-vessel disease; 2VD, 2-vessel disease; 3VD, 3-vessel illness; DES, Drug-eluting stent; BMS, Bare-metal stentJ Teh Univ Heart Ctr 12 (two) April, 2017 ://jthc.tums.ac.irNephroprotective Effects of L-Carnitine against Co.